1
|
Peralta G, Sánchez-Santiago B. Navigating the challenges of clinical trial professionals in the healthcare sector. Front Med (Lausanne) 2024; 11:1400585. [PMID: 38887672 PMCID: PMC11181308 DOI: 10.3389/fmed.2024.1400585] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2024] [Accepted: 05/13/2024] [Indexed: 06/20/2024] Open
Abstract
Clinical trials (CTs) are essential for medical advancements but face significant challenges, particularly in professional training and role clarity. Principal investigators, clinical research coordinators (CRCs), nurses, clinical trial pharmacists, and monitors are key players. Each faces unique challenges, such as maintaining protocol compliance, managing investigational products, and ensuring data integrity. Clinical trials' complexity and evolving nature demand specialized and ongoing training for these professionals. Addressing these challenges requires clear role delineation, continuous professional development, and supportive workplace environments to improve retention and trial outcomes. Enhanced training programs and a collaborative approach are essential for the successful conduct of clinical trials and the advancement of medical research.
Collapse
Affiliation(s)
- Galo Peralta
- Central Support Unit, Instituto de Investigación Marqués de Valdecilla (IDIVAL), Santander, Spain
| | - Blanca Sánchez-Santiago
- Clinical Pharmacology Service, Clinical Trials Unit, Hospital Universitario Marqués de Valdecilla, Instituto de Investigación Marqués de Valdecilla (IDIVAL), Santander, Spain
| |
Collapse
|
2
|
Showalter BL, Malecha A, Cesario S, Clutter P. Moral distress in clinical research nurses. Nurs Ethics 2022; 29:1697-1708. [PMID: 35730358 DOI: 10.1177/09697330221090613] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Background: Clinical research nurses experience unique challenges in the context of their role that can lead to conflict and moral distress. Although examined in many areas, moral distress has not been studied in clinical research nurses.Research aim: The aim of this study was to examine moral distress in clinical research nurses and the relationship between moral distress scores and demographic characteristics of clinical research nurses.Research design: This was a descriptive quantitative study to measure moral distress in clinical research nurses using the Measure of Moral Distress - Healthcare Professionals (MMD-HP) administered electronically. Demographic data were also collected.Participants and research context: Registered nurses working in the clinical research nurse role (N = 322) were recruited through use of social media, emails, digital flyers, and snowball recruitment. Data was analyzed using SPSS. Pearson's correlation, independent t-test, and one-way ANOVA were performed to explore differences among the demographic variables.Ethical considerations: This study was approved by the Institutional Review Board at Texas Woman's University. A consent statement was included, and completion of the questionnaire was construed as consent.Findings/results: Analysis revealed a mean overall moral distress score of 79.58 (SD = 64.27) and median of 67, with a range of 0-354. Moral distress scores were negatively correlated with clinical research nurse age (r = 0-.156, p < 0.05). Reliability of the MMD-HP was demonstrated with a Cronbach's alpha of 0.93.Conclusions: The findings demonstrate that clinical research nurses do experience moral distress and revealed a wide range of scores. Further research is necessary to determine potential patient impact due to moral distress and to develop processes to minimize moral distress in the clinical research setting. This study was conducted during the COVID-19 pandemic, and the digital recruitment methods proved effective in recruiting a wide range of clinical research nurses, both nationally and internationally.
Collapse
Affiliation(s)
- Brandi L Showalter
- 53626University of Texas Health Science Center, Houston, TX, USA; Texas Woman's University, Houston, TX, USA
| | - Ann Malecha
- 53626University of Texas Health Science Center, Houston, TX, USA
| | - Sandra Cesario
- 53626University of Texas Health Science Center, Houston, TX, USA
| | - Paula Clutter
- 53626University of Texas Health Science Center, Houston, TX, USA
| |
Collapse
|
3
|
Backman Lönn B, Hajdarevic S, Olofsson N, Hörnsten Å, Styrke J. Clarifying the role of clinical research nurses working in Sweden, using the Clinical Trial Nursing Questionnaire - Swedish version. Nurs Open 2022; 9:2434-2443. [PMID: 35652538 PMCID: PMC9374401 DOI: 10.1002/nop2.1260] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2021] [Revised: 12/27/2021] [Accepted: 05/06/2022] [Indexed: 11/30/2022] Open
Abstract
Aim To explore the role of CRNs in Sweden and differences in competences and tasks, using the Clinical Trial Nursing Questionnaire – Swedish version (CTNQ‐SWE). Design A cross‐sectional survey. Methods Participants were identified through strategic sampling. Data were analysed by descriptive and comparative statistics. Results The respondents were experienced nurses who felt proficient in their role, they felt more acceptance by the principal investigators than by nursing colleagues. A majority of CRNs are involved in all procedures specified in the CTNQ‐SWE. The most often performed tasks, also rated as the most important by the CRNs, concerned informed consent and management of investigational products. The education was often informal: with a lack of job descriptions and professional development plans. Need of formal specialist education was expressed. Conclusions Knowledge about the role description can be used by clinical research enterprise internationally and healthcare organizations aiming to support CRNs in their role.
Collapse
Affiliation(s)
- Beatrice Backman Lönn
- Department of Nursing, Umeå University, Umeå, Sweden.,Department of Research & Development, Region Västernorrland, Sundsvall Hospital, Sundsvall, Sweden
| | | | - Niclas Olofsson
- Department of Health Science, Mid Sweden University, Östersund, Sweden
| | - Åsa Hörnsten
- Department of Nursing, Umeå University, Umeå, Sweden
| | - Johan Styrke
- Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden
| |
Collapse
|
4
|
Jones CT, Griffith CA, Fisher CA, Grinke KA, Keller R, Lee H, Purdom M, Turba E. Nurses in clinical trials: perceptions of impact on the research enterprise. J Res Nurs 2022; 27:50-65. [PMID: 35392186 PMCID: PMC8980586 DOI: 10.1177/17449871211073757] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
Background Clinical Research Nurses practice across a wide spectrum of roles and settings within the global research enterprise. Clinical Research Nurses working with clinical trials face a dual fidelity in their role, balancing integrity of the protocol and quality care for participants. Aims The purpose of this study was to describe Clinical Research Nurses' experiences in clinical trials, educational preparation, and career pathways, to gain a deeper understanding of clinical research nursing contributions to the clinical research enterprise. Methods An internet-based survey was conducted to collect demographic data and free text responses to four open-ended queries related to the experience of nurses working in clinical trials research, educational preparation, and role pathways. Qualitative content analysis was used to analyze free text responses. The study was guided by the Clinical Research Nursing Domain of Practice and Duffy's Quality Caring Model of relationship centered professional encounters. Results Forty clinical research nurses responded to the open-ended questions with themes related to dual fidelity to study participants and protocols, relationships and nursing care, interdisciplinary team membership and contributing to science, emerging from the data. Gaps in educational preparation and professional pathways were identified. Conclusion This study provides insights to unique clinical research nurse practice contributions in the clinical trial research enterprise within a context of Duffy's Quality Caring Model.
Collapse
Affiliation(s)
- Carolynn T Jones
- Associate Professor, The Ohio State University, Columbus, OH, USA,Carolynn T Jones, College of Nursing, The Ohio State University, 1585 Neil Avenue, Columbus, OH 43210, USA.
| | - Catherine A Griffith
- Clinical Research Nurse, Patient Care Services, Massachusetts General Hospital, Boston, MA, USA
| | - Cheryl A Fisher
- Associate Professor, School of Nursing, Nursing Informatics, University of Maryland, Bethesda, MD, USA
| | - Kathleen A Grinke
- Clinical Research Nurse, Patient Care Services, Massachusetts General Hospital, Boston, MA, USA
| | - Rosemary Keller
- Clinician, Worldwide Research and Development/Safety, Pfizer, Inc., New York, NY, USA
| | - Hyacinth Lee
- Clinical Research Manager, ITHS Translational Research Unit, University of Washington, Seattle, WA, USA
| | - Michelle Purdom
- Vice President, Clinical Research and Operations, TG Therapeutics, Inc., New York, NY, USA
| | - Elyce Turba
- Clinical Research Nurse, Malignant Hematology Department, Moffitt Cancer Center, Tampa, FL, USA
| |
Collapse
|
5
|
Abstract
Background The role of Clinical Research Nurses across the globe has not been evaluated to identify similarities or differences among specific activities. Aims This study's aims were to determine differences in Clinical Research Nurses most frequently performed activities, if these activities are reflective of those previously described in the literature, and job titles Clinical Research Nurses use to self-identify. Methods An online cross-sectional survey distributed via snowball sampling through email, social media, and research nurses' networks included questions on frequency of activities performed and information related to job titles. Pearson's chi-square test is analyzed for associations between the groups. Results Respondents returned 252 questionnaires, 233 were eligible for analysis. Research nurse activities performed internationally showed both similarities and differences. Any between country comparisons will be limited to the United States and the United Kingdom. The three most common tasks reported were recruitment 120 (51.5%), monitoring the research participant for potential adverse events 187 (80.2%) and providing nursing leadership within the interdisciplinary team 169 (72.5%). Conclusion Considering the context and range of activities of the original Clinical Research Nursing Domain of Practice, broadening the framework to include the leadership domain will better serve as a foundation for the specialty practice.
Collapse
Affiliation(s)
- Cheryl A Fisher
- Associate Professor, Clinical Center Nursing Department, National Institutes of Health, Bethesda, MD, USA
| |
Collapse
|
6
|
Hong MN, Hayden KA, Bouchal SR, Sinclair S. Infirmière de recherche clinique en oncologie : revue exploratoire. Can Oncol Nurs J 2021; 31:150-164. [PMID: 34036154 PMCID: PMC8128430 DOI: 10.5737/23688076312150164] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Abstract
En ce 21e siècle, le cancer est une maladie qui suscite particulièrement l’attention en raison de sa complexité ainsi que des impacts physiques, émotionnels et financiers sur notre vie. L’attention portée à la recherche et les investissements dans le traitement contre le cancer en font la maladie la plus étudiée dans les essais cliniques à l’échelle mondiale. Les infirmières de recherche clinique font partie de l’équipe de recherche en oncologie et sont un élément fondamental de réussite des essais. Leurs relations directes avec les participants d’une étude de recherche sont essentielles pour les activités des essais cliniques en première ligne. De façon générale, l’afflux et la complexité des essais cliniques en oncologie ont transformé la pratique infirmière en oncologie et ont mené à la création de la sous-spécialité unique qu’est l’infirmière de recherche clinique en oncologie. La présente revue exploratoire s’est penchée sur le rôle et la pratique futurs de l’infirmière de recherche clinique.
Collapse
Affiliation(s)
- Mai N Hong
- Étudiante diplômée, Faculté des sciences infirmières, Université de Calgary, 2500 University Drive NW, Calgary (Alberta), Canada T2N 1N4
| | - K Alix Hayden
- bibliothécaire, Libraries & Cultural Resources, Université de Calgary, Taylor Family Digital Library, 2500 University Drive NW, Calgary (Alberta) T2N 1N4 Téléphone : 403-220-3752
| | - Shelley Raffin Bouchal
- professeure agrégée, Faculté des sciences infirmières, Université de Calgary, 2500 University Drive NW Calgary (Alberta), Canada T2N 1N4 Téléphone : 403-220-6258
| | - Shane Sinclair
- professeur agrégé, Faculté des sciences infirmières, Université de Calgary, 2500 University Drive NW, Calgary (Alberta), Canada T2N 1N4 ; Compassion Research Lab, Université de Calgary, 2500 University Drive NW Calgary (Alberta), Canada T2N 1N4 ; Department of Oncology, Cumming School of Medicine, Université de Calgary, 2500 University Drive NW, Calgary (Alberta) Canada T2N 1N4 Téléphone : 403-220-2925
| |
Collapse
|
7
|
Hong MN, Hayden A, Bouchal SR, Sinclair S. Oncology clinical trials nursing: A scoping review. Can Oncol Nurs J 2021; 31:137-149. [PMID: 34036153 PMCID: PMC8128434 DOI: 10.5737/23688076312137149] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Abstract
In the 21st century, cancer is a disease that captures much of our attention for its complexity, and its physical, emotional, and financial impacts on one's life. Research attention and investment in cancer management has made it the most studied disease in clinical trials globally. Clinical trials nurses are part of the oncology research team and a fundamental factor in trial success. Their direct relationship with research subjects is the key connection in the operation of clinical trials at the front line. The influx and complexity of oncology clinical trials has transformed both oncology nursing practice in general and led to the development of the unique subspecialty of the oncology clinical trials nurse. This scoping review investigated the role and future practice of the clinical trials nurse.
Collapse
Affiliation(s)
- Mai N Hong
- Graduate Student, Faculty of Nursing, University of Calgary, 2500 University Drive NW Calgary, AB T2N 1N4 K
| | - Alix Hayden
- Librarian, Libraries & Cultural Resources, University of Calgary Taylor Family Digital Library, 2500 University Drive NW, Calgary, AB T2N 1N4 Tel: 403-220-3752
| | - Shelley Raffin Bouchal
- Associate Professor, 1 Faculty of Nursing, University of Calgary, 2500 University Drive NW, Calgary, AB T2N 1N4. Tel: 403-220-6258
| | - Shane Sinclair
- Associate Professor, Faculty of Nursing, University of Calgary, 2500 University Drive NW, Calgary, AB T2N 1N4; Compassion Research Lab, University of Calgary, 2500 University Drive NW, Calgary, AB T2N 1N4; Department of Oncology, Cumming School of Medicine, University of Calgary, 2500 University Drive NW, Calgary, AB T2N 1N4. Tel: 403-220-2925
| |
Collapse
|
8
|
Forbes SG, Phillips CA. Ethical Challenges Encountered by Clinical Trials Nurses: A Grounded Theory Study. Oncol Nurs Forum 2020; 47:428-435. [PMID: 32555551 DOI: 10.1188/20.onf.428-435] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
OBJECTIVES To investigate the ethical challenges experienced by oncology clinical trials nurses (OCTNs) during the management of CTs and to examine how they resolve those conflicts. SAMPLE & SETTING 12 licensed RNs who had been practicing as full- or part-time OCTNs for a minimum of two years at various academic medical centers in the United States. METHODS & VARIABLES Classical grounded theory (CGT), an inductive methodology used to explore a social process in which little is known and to develop a theory grounded in the data, was used, in addition to CGT data analysis strategies. RESULTS CGT data analysis revealed the OCTNs' main concern (implementing an undefined job) and the way in which the OCTNs resolve this concern through the process of figuring it out. Figuring it out consists of learning as they go, utilizing their assets, standing their ground, and managing hope. IMPLICATIONS FOR NURSING Although some nursing research provides examples of ethical challenges OCTNs might encounter in practice, there is little information regarding how nurses manage those encounters. A theoretical understanding of the OCTNs' experiences managing ethical challenges fills a gap in the nursing literature and provides a framework for how OCTNs manage and respond to challenges in professional practice.
Collapse
|
9
|
Ness E. The Oncology Clinical Research Nurse Study Co-Ordinator: Past, Present, and Future. Asia Pac J Oncol Nurs 2020; 7:237-242. [PMID: 32642493 PMCID: PMC7325777 DOI: 10.4103/apjon.apjon_10_20] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2020] [Accepted: 04/08/2020] [Indexed: 11/04/2022] Open
Abstract
Clinical research nursing is a specialty practice that has evolved over the past century. Clinical research nurses (CRNs) work directly (e.g., direct care provider and advance clinician) or indirectly (e.g., manager, educator, and study co-ordinator) to support clinic research. For more than 50 years, oncology nurses have contributed to the body of evidence describing and validating the responsibilities and importance of the nurse in clinical research, especially the study co-ordinator role. This article will focus on the CRN study co-ordinator role in oncology clinical trials highlighting the historical evolution of the role, the contributions of dedicated members of the Oncology Nursing Society, and the future landscape of clinical research nursing through the International Association of CRNs.
Collapse
Affiliation(s)
- Elizabeth Ness
- Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
| |
Collapse
|
10
|
Good M, Castro K, Denicoff A, Finnigan S, Parreco L, Germain DS. National Cancer Institute: Restructuring to Support the Clinical Trials of the Future. Semin Oncol Nurs 2020; 36:151003. [PMID: 32265163 DOI: 10.1016/j.soncn.2020.151003] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
OBJECTIVES To describe the evolution and structure of the National Cancer Institute clinical trials programs, their notable accomplishments, nurses' roles in these accomplishments, and the essential role of nursing today and in the future. DATA SOURCES Manuscripts, government publications, websites, and professional communications. CONCLUSION Change is inevitable and a constant factor in the world of advancing science and clinical research. Nurses' contribution to research and evidence-based practice will continue to grow and is vital as the scientific landscape evolves. IMPLICATIONS FOR NURSING PRACTICE As the understanding of cancer biology increases and clinical trials evolve, nurses will need to remain key team members and leaders in National Cancer Institute Community Oncology Research Program and National Cancer Trials Network trials and their associated infrastructure.
Collapse
Affiliation(s)
- Marjorie Good
- Division of Cancer Prevention, National Cancer Institute, Rockville, MD.
| | - Kathleen Castro
- Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD
| | - Andrea Denicoff
- Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, MD
| | - Shanda Finnigan
- Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, MD
| | - Linda Parreco
- Division of Cancer Prevention, National Cancer Institute, Rockville, MD
| | - Diane St Germain
- Division of Cancer Prevention, National Cancer Institute, Rockville, MD
| |
Collapse
|
11
|
Hernon O, Dalton R, Dowling M. Clinical research nurses’ expectations and realities of their role: A qualitative evidence synthesis. J Clin Nurs 2019; 29:667-683. [DOI: 10.1111/jocn.15128] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2019] [Revised: 11/18/2019] [Accepted: 11/24/2019] [Indexed: 01/01/2023]
Affiliation(s)
- Orlaith Hernon
- Galway University Hospital Newcastle Road Galway Ireland
| | - Rachael Dalton
- Galway University Hospital Newcastle Road Galway Ireland
| | - Maura Dowling
- School of Nursing and Midwifery National University of Ireland Galway Ireland
| |
Collapse
|
12
|
Babiker HM, Davis L, Larson K, Placencia C, Swensen C, Tenneti P, Lim M, Cañamar R, Curtis J, Castillo E, Mancuso J, Rensvold D, Martinez S, Macias L, Recio-Boiles A, Chandana SR, Mahadevan D. A Multidisciplinary Evaluation of Barriers to Enrolling Cancer Patients into Early Phase Clinical Trials: Challenges and Patient-centric Recommendations. Expert Opin Investig Drugs 2019; 28:675-686. [PMID: 31327293 DOI: 10.1080/13543784.2019.1646726] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
Introduction: Early phase clinical trials are the first clinical research step to bringing new cancer therapeutics to patients. At this stage, a new drug's safety, dosing, and scheduling profiles are established as the main endpoints. However, excellent responses due to biomarker-guided and immune checkpoint trials in early phase have resulted in direct approvals of new anti-cancer drugs. Despite doubling of the success rate of new drug approvals, many barriers exist to expeditiously bring active new drugs to the clinic. Areas covered: This review covers roles of members of the early phase program and the challenges they face in enrolling advanced cancer patients to trials. Practical solutions are provided from the perspective of the investigators, regulatory, investigational pharmacy, research nurses, clinical research coordinators, budgets, contracts, and data management. Expert opinion: We are witnessing a burgeoning era in drug development with rapid approval of efficacious drugs. This is achieved by a strong collaboration between investigators, academic institutions, pharmaceutical sponsors, scientists, Food and Drug Administration (FDA), and community practices. Herein, we discuss some of the challenges faced by early phase clinical trials programs and discuss methods of improvement.
Collapse
Affiliation(s)
- Hani M Babiker
- a Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program , Tucson , AZ , USA
| | - Lisa Davis
- a Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program , Tucson , AZ , USA
| | - Kristian Larson
- a Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program , Tucson , AZ , USA
| | - Crystal Placencia
- a Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program , Tucson , AZ , USA
| | - Connor Swensen
- a Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program , Tucson , AZ , USA
| | - Pavan Tenneti
- b Department of Medicine, Banner University Medical Center Phoenix , Phoenix , AZ , USA
| | - Melissa Lim
- a Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program , Tucson , AZ , USA
| | - Ruth Cañamar
- a Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program , Tucson , AZ , USA
| | - Jacqueline Curtis
- a Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program , Tucson , AZ , USA
| | - Erica Castillo
- a Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program , Tucson , AZ , USA
| | - James Mancuso
- c Department of Immunology, University of Texas MD Anderson Cancer Center , Houston , TX , USA
| | - Diane Rensvold
- a Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program , Tucson , AZ , USA
| | - Sarah Martinez
- a Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program , Tucson , AZ , USA
| | - Lora Macias
- a Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program , Tucson , AZ , USA
| | - Alejandro Recio-Boiles
- a Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program , Tucson , AZ , USA
| | - Sreenivasa R Chandana
- d Department of Gastrointestinal Medical Oncology, Cancer and Hematology Centers of Western Michigan, Phase I Program, START Midwest , Grand Rapids , MI , USA
| | - Daruka Mahadevan
- a Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program , Tucson , AZ , USA
| |
Collapse
|
13
|
Backman Lönn B, Olofsson N, Jong M. Translation and validation of the Clinical Trial Nursing Questionnaire in Swedish-A first step to clarify the clinical research nurse role in Sweden. J Clin Nurs 2019; 28:2696-2705. [PMID: 30938002 DOI: 10.1111/jocn.14855] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2018] [Revised: 03/14/2019] [Accepted: 03/21/2019] [Indexed: 11/30/2022]
Abstract
AIM AND OBJECTIVES To translate the Clinical Trial Nursing Questionnaire (CTNQ) into Swedish and test it for face and content validity as well as internal consistency and reproducibility using test-retest procedures. INTRODUCTION/BACKGROUND In many countries, as in Sweden, a registered nurse can be involved in research by becoming a clinical research nurse. The clinical research nurse plays a pivotal role in clinical studies as a part of the research team. Scales have been developed and used with the objective to clarify the role of clinical research nurses: one of them is the CTNQ. METHODS A quantitative cross-sectional design with a test-retest procedure was applied to validate the translated questionnaire. By using a snowball sampling method, relevant participants were identified and 49 registered nurses working in the field of research as clinical research nurses answered the questionnaire on two occasions. An expert panel of three clinical research nurses evaluated the questionnaire for face and content validity. The STROBE checklist for observational research has been followed for presenting the research (see File S1). RESULTS Face and content validity was agreed upon in the expert panel group. Tests for internal consistency of the CTNQ was calculated and showed a high Cronbach's alpha for both the frequency and importance subscales. The test-retest correlation analysis (reproducibility) also revealed a high correlation coefficient for both subscales. CONCLUSION The CTNQ-SWE is a valid and robust instrument in a Swedish version. The instrument can be of importance in assessing the role of clinical research nurses in Sweden in future studies. RELEVANCE TO CLINICAL PRACTICE Use of the CTNQ-SWE in future research can be of value for clarification and professional development of the clinical research nurse role in Sweden. The further use of the CTNQ in Sweden can be of value in understanding the process where licensed nurses make a transition into becoming a clinical research nurse, and to identify needs for customised education.
Collapse
Affiliation(s)
- Beatrice Backman Lönn
- Department of Research & Development, Region Västernorrland, Sundsvall Hospital, Sundsvall, Sweden
| | - Niclas Olofsson
- Department of Research & Development, Region Västernorrland, Sundsvall Hospital, Sundsvall, Sweden.,Department of Health Science, Mid Sweden University, Östersund, Sweden
| | - Mats Jong
- Department of Sport Science, Mid Sweden University, Östersund, Sweden
| |
Collapse
|
14
|
Abstract
Part of my clinical role involves educating and informing patients about the risks and benefits of the various treatment options related to prostate cancer. Like many bed- or chairside nurses, I spend a lot of time talking and listening to my patients. I am sometimes surprised when I get a call from a patient who seemingly did not hear or understand something that I told him or her. I know I told the patient, and I think I am a good educator, so why the confusion? The answer is, in part, simple-health literacy (or the lack thereof).
.
Collapse
|
15
|
Gborogen R, Polek C. Oral Agents: Challenges With Self-Administered Medication Adherence in Clinical Trials. Clin J Oncol Nurs 2018; 22:333-339. [PMID: 29781461 DOI: 10.1188/18.cjon.333-339] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
BACKGROUND In oral agent clinical trials, patients may not be adherent to self-administration of study medication; this nonadherence can affect validity and reliability. Many factors contribute to nonadherence to protocol requirements, and managing patients with fidelity issues is the responsibility of the research team. OBJECTIVES The aim is to identify which group (patients, physicians/principal investigators, nurses, or other personnel) research nurses report as most responsible for protocol nonadherence and to characterize the most observed causes and contributors to nonadherence within each group. METHODS Sixty-seven protocol nurses completed a nine-question survey developed from pilot data. Descriptive statistics and ordinal regressions addressed the objectives of the study. FINDINGS More than half of the nurses observed clinical trial nonadherence in their practices. Nurses identified challenges regarding physician, patient, and nurse factors. The most frequently identified causes included patients' forgetfulness, refusal to undergo study procedures, inadequate family or caregiver support to complete study activities, ineffective communication, and collaboration within the research team.
Collapse
|